LAPTM5 and renal cell carcinoma: By integrated analyses of transcriptional profiles in clinical samples and Rencaluci RCC cell line derivatives with distinct organ metastasis tendency, we showed that LAPTM5 was preferentially activated in lung metastasis and was required for RCC cells to develop lung-specific metastases.